<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39422832</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2364-1746</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Pulmonary therapy</Title><ISOAbbreviation>Pulm Ther</ISOAbbreviation></Journal><ArticleTitle>Efficacy of High Flow Nasal Cannula in the Treatment of Patients with COVID-19 with Acute Respiratory Distress Syndrome: Results of Single Centre Study in Vietnam.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s41030-024-00272-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Most hospitalized patients required invasive or non-invasive ventilation and High Flow Nasal Cannula (HFNC). Therefore, this study was conducted to describe the characteristics of patients with severe Coronavirus Disease-2019 (COVID-19) treated by HFNC and its effectiveness for reducing the rate of intubated-mechanical ventilation in the Intensive Care Unit (ICU) of Phu Chanh COVID-19 Department-Binh Duong General Hospital.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">It was a cross-sectional and descriptive study. All severe patients with COVID-19 with acute respiratory failure eligible for the study were included. Patient characteristics, clinical symptoms, laboratory results, and treatment methods were collected for analysis; parameters and data related to HFNC treatment and follow-up were analysed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">80 patients, aged of 49.7 ± 16.6 years, were treated with HFNC at admission in ICU. 14 patients had type 2 diabetes (17.5%), 3 patients had chronic respiratory disease (3.8%), 19 patients had high blood pressure (23.8%), and 5 patients with other comorbidities (7.4%). The majority of patients with severe COVID-19 had typical symptoms of COVID-19 such as shortness of breath (97.5%), intensive tired (81.3%), cough (73.7%), anosmia (48.3%), ageusia (41.3%), and fever (26.3%). The results of arterial blood gases demonstrated severe hypoxia under optimal conventional oxygen therapy (PaO<sub>2</sub> = 52.5 ± 17.4 mmHg). Respiratory rate, SpO2, PaO2 were significantly improved after using HFNC at 1st day, 3rd day and 7th day (P &lt; 0.05; P &lt; 0.05; P &lt; 0.01; respectively). Receiver operating characteristics (ROC) index was significantly increased after treating with HFNC vs before HFNC treatment (4.79 ± 1.86, 5.53 ± 2.39, and 7.41 ± 4.24 vs 2.97 ± 0.39; P &lt; 0.05, P &lt; 0.05 and P &lt; 0.01, respectively). 54 (67.5%) patients were success with HFNC treatment and 26 (32.5%) patients with HFNC failure needed to treat with Continuous Positive Airway Pressure (CPAP) (13 patients; 50%) or intubated ventilation (13 patients; 50%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">HFNC therapy could be considered as a useful and effective alternative treatment for patients with acute respiratory failure. HFNC might help to delay the intubated ventilation for patients with respiratory failure and to minimise the risk of invasive ventilation complications and mortality. However, it is crucial to closely monitor the evolution of patient's respiratory status and responsiveness of HFNC treatment to avoid unintended delay of intubation-mechanical ventilation.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">An independent ethics committee approved the study (The Ethics Committee of Binh Duong General Hospital; No. HDDD-BVDK BINH DUONG 9.2021), which was performed in accordance with the Declaration of Helsinki, Guidelines for Good Clinical Practice.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duong-Quy</LastName><ForeName>Sy</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5926-9544</Identifier><AffiliationInfo><Affiliation>Biomedical Research Centre, Lam Dong Medical College, Dalat City, Vietnam. sduongquy.jfvp@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outpatient Department of Pham Ngoc, Thach University, Ho Chi Minh City, Vietnam. sduongquy.jfvp@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immuno-Allergology and Respiratory Department, Hershey Medical Center, Hershey, PA, USA. sduongquy.jfvp@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huynh-Truong-Anh</LastName><ForeName>Duc</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Intensive Care Unit of Covid 19, Binh Duong General Hospital, Ho Chi Minh City, Binh Duong Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang-Thi-Thao</LastName><ForeName>Tram</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Biomedical Research Centre, Lam Dong Medical College, Dalat City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Ngoc-Phuong</LastName><ForeName>Thu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Outpatient Department of Pham Ngoc, Thach University, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoang-Phi-Tuyet</LastName><ForeName>Phung</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biomedical Research Centre, Lam Dong Medical College, Dalat City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Tuan</LastName><ForeName>Anh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biomedical Research Centre, Lam Dong Medical College, Dalat City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Van</LastName><ForeName>Toi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Biomedical Research Centre, Lam Dong Medical College, Dalat City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Chi</LastName><ForeName>Thanh</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Intensive Care Unit of Covid 19, Binh Duong General Hospital, Ho Chi Minh City, Binh Duong Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Thi-Kim</LastName><ForeName>Thanh</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Intensive Care Unit of Covid 19, Binh Duong General Hospital, Ho Chi Minh City, Binh Duong Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Quang</LastName><ForeName>Tien</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Intensive Care Unit of Covid 19, Binh Duong General Hospital, Ho Chi Minh City, Binh Duong Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran-Ngoc-Anh</LastName><ForeName>Thuy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Intensive Care Unit of Covid 19, Binh Duong General Hospital, Ho Chi Minh City, Binh Duong Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Van-Hoai</LastName><ForeName>Nam</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Intensive Care Unit of Covid 19, Binh Duong General Hospital, Ho Chi Minh City, Binh Duong Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Do-Thi-Thu</LastName><ForeName>Mai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intensive Care Unit of Covid 19, Binh Duong General Hospital, Ho Chi Minh City, Binh Duong Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoang-Thi-Xuan</LastName><ForeName>Huong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Nursing Faculty, Phenikaa University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Duy</LastName><ForeName>Thai</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Institute for Control of Vaccines and Biologicals, Ministry of Health, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Hai</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Tuberculosis and Respiratory Pathology, Military Hospital 175, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huynh-Anh</LastName><ForeName>Tuan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Respiratory Diseases, Hoan My General Hospital, Cái Răng, Can Tho Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu-Tran-Thien</LastName><ForeName>Quan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Respiratory Functional Exploration, University Medical Centre, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bui-Diem</LastName><ForeName>Khue</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Respiratory Functional Exploration, University Medical Centre, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Mong</LastName><ForeName>Giang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Sciences and Technology, Ho Chi Minh City, Binh Duong Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Lan</LastName><ForeName>Hieu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Intensive Care Unit of Covid 19, Binh Duong General Hospital, Ho Chi Minh City, Binh Duong Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu-Van</LastName><ForeName>Giap</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Respiratory Centre, Bach Mai Hospital, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phan-Thu</LastName><ForeName>Phuong</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Respiratory Centre, Bach Mai Hospital, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Viet</LastName><ForeName>Long</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Sciences and Technology, Ho Chi Minh City, Binh Duong Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Hong</LastName><ForeName>Chuong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Health, Ho Chi Minh City, Binh Duong Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dinh-Ngoc</LastName><ForeName>Sy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Respiratory Department, National Hospital of Lung Diseases, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Duc</LastName><ForeName>Trong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Thang Long University, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Truong-Viet</LastName><ForeName>Dung</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Thang Long University, Hanoi City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vo-Pham-Minh</LastName><ForeName>Thu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Respiratory Department, Can Tho University of Medecine and Pharmacy, Can Tho Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le-Khac</LastName><ForeName>Bao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Phoi Viet Clinic, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Hong</LastName><ForeName>Duc</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Phoi Viet Clinic, Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine. School of Medicine, Tan Tao University, Đức Hòa, Long An Province, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craig</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Immuno-Allergology and Respiratory Department, Hershey Medical Center, Hershey, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen-Nhu</LastName><ForeName>Vinh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Respiratory Functional Exploration, University Medical Centre, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. vinhnguyenmd@ump.edu.vn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pulm Ther</MedlineTA><NlmUniqueID>101687144</NlmUniqueID><ISSNLinking>2364-1754</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Binh Duong province</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HFNC</Keyword><Keyword MajorTopicYN="N">Intubation—mechanical ventilation</Keyword><Keyword MajorTopicYN="N">ROX index</Keyword><Keyword MajorTopicYN="N">Respiratory failure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39422832</ArticleId><ArticleId IdType="doi">10.1007/s41030-024-00272-0</ArticleId><ArticleId IdType="pii">10.1007/s41030-024-00272-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li Y, Li C, Chang W, Liu L. High-flow nasal cannula reduces intubation rate in patients with COVID-19 with acute respiratory failure: a meta-analysis and systematic review. BMJ Open. 2023;13(3): e067879. https://doi.org/10.1136/bmjopen-2022-067879 . (PMID:36997243;PMCID:PMC10069279).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-067879</ArticleId><ArticleId IdType="pubmed">36997243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee D, Mukherjee R. High-flow nasal cannula oxygen therapy in the management of respiratory failure: a review. Cureus. 2023;15(12): e50738. https://doi.org/10.7759/cureus.50738 . (PMID:38111819;PMCID:PMC10727693).</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.50738</ArticleId><ArticleId IdType="pubmed">38111819</ArticleId><ArticleId IdType="pmc">10727693</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW; the Northwell COVID-19 Research Consortium; Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059. https://doi.org/10.1001/jama.2020.6775 . (PMC7177629).</Citation></Reference><Reference><Citation>Hasan SS, Capstick T, Ahmed R, Kow CS, Mazhar F, Merchant HA, Zaidi STR. Mortality in patients with COVID-19 with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020;14(11):1149–63. https://doi.org/10.1080/17476348.2020.1804365 . (Epub 2020 Sep 29. PMID: 32734777; PMCID: PMC7544968).</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2020.1804365</ArticleId><ArticleId IdType="pubmed">32734777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Liao G, Mao J, Yan H, Chen J, Peng J. Factors associated with mortality among severe omicron patients for COVID-19. Infect Drug Resist. 2024;3(17):1309–19. https://doi.org/10.2147/IDR.S450504 . (PMID:38585415;PMCID:PMC10999197).</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S450504</ArticleId></ArticleIdList></Reference><Reference><Citation>Bime C, Carr GE, Pu J, Kou S, Wang Y, Simons M. Delayed intubation associated with in-hospital mortality in patients with COVID-19 respiratory failure who fail heated and humified high flow nasal canula. BMC Anesthesiol. 2023;23(1):234. https://doi.org/10.1186/s12871-023-02198-7 . (PMID:37438685;PMCID:PMC10337200).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-023-02198-7</ArticleId><ArticleId IdType="pubmed">37438685</ArticleId><ArticleId IdType="pmc">10337200</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandel A, Patolia S, Brown AW, Collins AC, Sahjwani D, Khangoora V, Cameron PC, Desai M, Kasarabada A, Kilcullen JK, Nathan SD, King CS. High-flow nasal cannula therapy in COVID-19: using the ROX index to predict success. Respir Care. 2021;66(6):909–19. https://doi.org/10.4187/respcare.08631 . (Epub 2020 Dec 16 PMID: 33328179).</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.08631</ArticleId><ArticleId IdType="pubmed">33328179</ArticleId></ArticleIdList></Reference><Reference><Citation>Suffredini DA, Allison MG. A rationale for use of high flow nasal cannula for select patients with suspected or confirmed severe acute respiratory syndrome coronavirus-2 infection. J Intensive Care Med. 2021;36(1):9–17. https://doi.org/10.1177/0885066620956630 . (Epub 2020 Sep 10 PMID: 32912049).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066620956630</ArticleId><ArticleId IdType="pubmed">32912049</ArticleId></ArticleIdList></Reference><Reference><Citation>Maia IS, Kawano-Dourado L, Zampieri FG, Damiani LP, Nakagawa RH, Gurgel RM, Negrelli K, Gomes SPC, Paisani D, Lima LM, Santucci EV, Valeis N, Laranjeira LN, Lewis R, Fitzgerald M, Carvalho CRR, Brochard L, Cavalcanti AB; RENOVATE Investigators and the BRICNet. High flow nasal catheter therapy versus non-invasive positive pressure ventilation in acute respiratory failure (RENOVATE trial): protocol and statistical analysis plan. Crit Care Resusc. 2023;24(1):61–70. https://doi.org/10.51893/2022.1.OA8 . (PMID: 38046839; PMCID: PMC10692619).</Citation></Reference><Reference><Citation>Lionello F, Lapia F, Molena B, Padoan A, Lococo S, Arcaro G, Guarnieri G, Vianello A. The safety of a high-flow nasal cannula in neuromuscular disease patients with acute respiratory failure: a retrospective case-series study. J Clin Med. 2023;12(18):6061. https://doi.org/10.3390/jcm12186061 . (PMID:37763001;PMCID:PMC10531616).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12186061</ArticleId><ArticleId IdType="pubmed">37763001</ArticleId><ArticleId IdType="pmc">10531616</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Tan C, Jiang H. High-flow nasal cannula oxygen therapy is superior to conventional oxygen therapy in intensive care unit patients after extubation. Am J Transl Res. 2023;15(2):1239–46.</Citation><ArticleIdList><ArticleId IdType="pubmed">36915743</ArticleId><ArticleId IdType="pmc">10006799</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan ML, Thomas GB. A rare complication of pneumopericardium, spontaneous pneumothorax, and subcutaneous emphysema in a COVID-19 pneumonia patient treated with high flow nasal cannula. Cureus. 2022;14(5): e24795. https://doi.org/10.7759/cureus.24795 . (PMID:35686259;PMCID:PMC9170430).</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.24795</ArticleId><ArticleId IdType="pubmed">35686259</ArticleId><ArticleId IdType="pmc">9170430</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalewajska M, Feret W, Wojczyński Ł, Witkiewicz W, Wiśniewska M, Kotfis K. Spontaneous pneumothorax in patients with covid-19 treated with high-flow nasal cannula outside the ICU: a case series. Int J Environ Res Public Health. 2021;18(4):2191. https://doi.org/10.3390/ijerph18042191 . (PMID:33672281;PMCID:PMC7926594).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18042191</ArticleId><ArticleId IdType="pubmed">33672281</ArticleId><ArticleId IdType="pmc">7926594</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Nufaiei ZF, Al Zhranei RM. High-flow nasal cannula oxygen therapy versus non-invasive ventilation in patients at very high risk for extubating failure: a systematic review of randomized controlled trials. PLoS One. 2024;19(4): e0299693. https://doi.org/10.1371/journal.pone.0299693 . (PMID:38568930;PMCID:PMC10990192).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0299693</ArticleId><ArticleId IdType="pubmed">38568930</ArticleId><ArticleId IdType="pmc">10990192</ArticleId></ArticleIdList></Reference><Reference><Citation>Reta-Pérez O, Colmenero-Ruiz M, Hernández-Socorro CR, Saavedra P, Maichle SF, Portugal E, Cerezo-Arias M, Sánchez Alés L, Martínez-Carmona JF, Mateu-Campos L, Lorencio-Cárdenas C, García-Miguélez A, Sosa-Durr M, San Martín-Bragado M, Ruiz-Santana S. Trophic nutrition in ICU patients undergoing high-flow oxygen therapy and/or noninvasive mechanical ventilation: the nutri-trophic study. Nutrients. 2024;16(9):1366. https://doi.org/10.3390/nu16091366 . (PMID:38732612;PMCID:PMC11085204).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu16091366</ArticleId><ArticleId IdType="pubmed">38732612</ArticleId><ArticleId IdType="pmc">11085204</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Tan C, Jiang H. High-flow nasal cannula oxygen therapy is superior to conventional oxygen therapy in intensive care unit patients after extubation. Am J Transl Res. 2023;15(2):1239–46 (PMID: 36915743; PMCID: PMC10006799).</Citation><ArticleIdList><ArticleId IdType="pubmed">36915743</ArticleId><ArticleId IdType="pmc">10006799</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu DY, Dai B, Tan W, Zhao HW, Wang W, Kang J. Effectiveness of the use of a high-flow nasal cannula to treat patients with COVID-19 and risk factors for failure: a meta-analysis. Ther Adv Respir Dis. 2022;16:17534666221091932. https://doi.org/10.1177/17534666221091931 . (PMID: 35467449; PMCID: PMC9047804).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17534666221091931</ArticleId><ArticleId IdType="pubmed">35467449</ArticleId><ArticleId IdType="pmc">9047804</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong-Quy S, Huynh Truong Anh D, Nguyen Thi Kim T, Nguyen Quang T, Tran Ngoc Anh T, Nguyen Van Hoai N, Do Thi Thu M, Nguyen-Van T, Tang-Thi-Thao T, Nguyen-Tuan A, Trinh Du T, Tran Thai T, Nguyen Van T. Clinical process in indications and application of HFNC therapy in patients with severe Covid-19. J Func Vent Pulm 2023;41(14):13–21. https://scholar.google.com/citations?view_op=view_citation&amp;hl=fr&amp;user=DHirR5AAAAAJ&amp;sortby=pubdate&amp;citation_for_view=DHirR5AAAAAJ:D4n_APcuzvwC</Citation></Reference><Reference><Citation>Chaudhuri D, Sasaki K, Karkar A, Sharif S, Lewis K, Mammen MJ, Alexander P, Ye Z, Lozano LEC, Munch MW, Perner A, Du B, Mbuagbaw L, Alhazzani W, Pastores SM, Marshall J, Lamontagne F, Annane D, Meduri GU, Rochwerg B. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intensive Care Med. 2021;47(5):521–37. https://doi.org/10.1007/s00134-021-06394-2 . (Epub 2021 Apr 19. PMID: 33876268; PMCID: PMC8054852).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06394-2</ArticleId><ArticleId IdType="pubmed">33876268</ArticleId><ArticleId IdType="pmc">8054852</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong-Quy S, Huynh-Truong-Anh D, Nguyen-Quang T, Nguyen-Thi-Kim T, Tran-Ngoc-Anh T, Nguyen-Van-Hoai N, Do-Thi-Thu M, Nguyen-Van T, Tang-Thi-Thao T, Nguyen-Tuan A, Nguyen-Van T, Tran-Xuan Q, Vu-Tran-Thien Q, Trinh-Du T, Tran-Thai T, Nguyen-Duy T, Tran-Van H, Vo-Thi-Kim A. Guillain–Barré syndrome due to COVID-19 vero cell vaccination associated with concomitant COVID-19 infection-induced ards and treated successfully by therapeutic plasma exchange: a first case report from Vietnam. Pulm Ther. 2023;9(2):271–80. https://doi.org/10.1007/s41030-023-00219-x . (Epub 2023 Mar 29. PMID: 36991236; PMCID: PMC10057680).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41030-023-00219-x</ArticleId><ArticleId IdType="pubmed">36991236</ArticleId><ArticleId IdType="pmc">10057680</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong-Quy S, Huynh-Truong-Anh D, Nguyen-Thi-Kim T, Nguyen-Quang T, Nguyen-Chi T, Nguyen-Thi-Y N, Duong-Thi-Thanh V, Ngo C, Craig T. the use of therapeutic plasma exchange in the treatment of a pregnant woman with COVID-19 induced acute respiratory distress syndrome. Pulm Ther. 2022;8(2):233–40. https://doi.org/10.1007/s41030-022-00188-7 . (Epub 2022 Apr 15. PMID: 35426596; PMCID: PMC9011376).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41030-022-00188-7</ArticleId><ArticleId IdType="pubmed">35426596</ArticleId><ArticleId IdType="pmc">9011376</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Huang Z, Tan W, Li X, Yin W, Xiao Y, Tao Z, Geng S, Hu Y. Predictive factors of severe coronavirus disease 2019 in previously healthy young adults: a single-center, retrospective study. Respir Res. 2020;21(1):157. https://doi.org/10.1186/s12931-020-01412-1.PMID:32571410;PMCID:PMC7306646 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01412-1.PMID:32571410;PMCID:PMC7306646</ArticleId><ArticleId IdType="pubmed">32571410</ArticleId><ArticleId IdType="pmc">7306646</ArticleId></ArticleIdList></Reference><Reference><Citation>Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, Demertzis Z, Hanna Z, Failla A, Dagher C, Chaudhry Z, Vahia A, Abreu Lanfranco O, Ramesh M, Zervos MJ, Alangaden G, Miller J, Brar I. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan detroit. JAMA Netw Open. 2020;3(6): e2012270. https://doi.org/10.1001/jamanetworkopen.2020.12270 . (PMID:32543702;PMCID:PMC7298606).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.12270</ArticleId><ArticleId IdType="pubmed">32543702</ArticleId><ArticleId IdType="pmc">7298606</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong-Quy S, Huynh-Truong-Anh D, Nguyen-Thi-Kim T, Nguyen-Quang T, Tran-Ngoc-Anh T, Nguyen-Van-Hoai N, Do-Thi-Thu M, Nguyen-Chi T, Nguyen-Van T, Tang-Thi-Thao T, Nguyen-Tuan A, Nguyen-Hoang Q, Hoang-Phi-Tuyet P, Vu-Van G, Nguyen-Lan H, Nguyen-Hong C, Dinh-Ngoc S, Truong-Viet D, Nguyen-Nhu V, Nguyen-Duy T. Predictive factors of mortality in patients with severe COVID-19 treated in the intensive care unit: a single-center study in Vietnam. Pulm Ther. 2023;9(3):377–94. https://doi.org/10.1007/s41030-023-00231-1 . (Epub 2023 Jul 7. PMID: 37415031; PMCID: PMC10447826).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41030-023-00231-1</ArticleId><ArticleId IdType="pubmed">37415031</ArticleId><ArticleId IdType="pmc">10447826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hai CN, Duc TB, Minh TN, Quang LN, Tung SLC, Duc LT, Duong-Quy S. Predicting mortality risk in hospitalized patients with COVID-19: an early model utilizing clinical symptoms. BMC Pulm Med. 2024;24(1):24. https://doi.org/10.1186/s12890-023-02838-1 . (PMID:38200490; PMCID: PMC10777603).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-023-02838-1</ArticleId><ArticleId IdType="pubmed">38200490</ArticleId><ArticleId IdType="pmc">10777603</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, Wu Y, Sun L, Xu Y. Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol. 2020;127:104371. https://doi.org/10.1016/j.jcv.2020.104371 . (Epub 2020 Apr 14. PMID: 32315817; PMCID: PMC7195434).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104371</ArticleId><ArticleId IdType="pubmed">32315817</ArticleId><ArticleId IdType="pmc">7195434</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng S, Mei Q, Zhu C, Yang T, Yang Y, Fang X, Pan A. High flow nasal cannula is a good treatment option for COVID-19. Heart Lung. 2020;49(5):444–5. https://doi.org/10.1016/j.hrtlng.2020.03.018 . (Epub 2020 Apr 11. PMID: 32295710; PMCID: PMC7151489).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2020.03.018</ArticleId><ArticleId IdType="pubmed">32295710</ArticleId><ArticleId IdType="pmc">7151489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Zhao W, Li J, Shu W, Duan J. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China. Ann Intensive Care. 2020;10(1):37. https://doi.org/10.1186/s13613-020-00653-z . (PMID:32232685; PMCID:PMC7104710).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00653-z</ArticleId><ArticleId IdType="pubmed">32232685</ArticleId><ArticleId IdType="pmc">7104710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Baek AR, Lee SI, Kim WY, Na YS, Lee BY, Seong GM, Baek MS. ROX index and SpO2/FiO2 ratio for predicting high-flow nasal cannula failure in hypoxemic Patients with COVID-19: a multicenter retrospective study. PLoS One. 2022;17(5): e0268431. https://doi.org/10.1371/journal.pone.0268431 . (PMID:35551328;PMCID:PMC9098056).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0268431</ArticleId><ArticleId IdType="pubmed">35551328</ArticleId><ArticleId IdType="pmc">9098056</ArticleId></ArticleIdList></Reference><Reference><Citation>Monro-Somerville T, Sim M, Ruddy J, Vilas M, Gillies MA. The Effect of high-flow nasal cannula oxygen therapy on mortality and intubation rate in acute respiratory failure: a systematic review and meta-analysis. Crit Care Med. 2017;45(4):e449–56. https://doi.org/10.1097/CCM.0000000000002091 . (PMID: 27611978).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002091</ArticleId><ArticleId IdType="pubmed">27611978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JC, Peng Y, Dai B, Hou HJ, Zhao HW, Wang W, Tan W. Comparison between high-flow nasal cannula and conventional oxygen therapy in Patients with COVID-19: a systematic review and meta-analysis. Ther Adv Respir Dis. 2024;18:17534666231225324. https://doi.org/10.1177/17534666231225323 . (PMID: 38230522; PMCID: PMC10798115).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17534666231225323</ArticleId><ArticleId IdType="pubmed">38230522</ArticleId><ArticleId IdType="pmc">10798115</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Pape S, Savart S, Arrivé F, Frat JP, Ragot S, Coudroy R, Thille AW. High-flow nasal cannula oxygen versus conventional oxygen therapy for acute respiratory failure due to COVID-19: a systematic review and meta-analysis. Ann Intensive Care. 2023;13(1):114. https://doi.org/10.1186/s13613-023-01208-8 . (PMID:37994981; PMCID:PMC10667189).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-023-01208-8</ArticleId><ArticleId IdType="pubmed">37994981</ArticleId><ArticleId IdType="pmc">10667189</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt FM, Nowak L, Obereisenbuchler F, Hetrodt J, Heiß-Neumann M, Schönlebe A, et al. Predicting the effectiveness of high-flow oxygen therapy in COVID-19 patients: a single-centre observational study. Anaesthesiol Intens Ther. 2022;54(1):12–7. https://doi.org/10.5114/ait.2022.113738 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ait.2022.113738</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruchiwit P, Madua J, Saiphoklang N. Comparison of ROX, HROX, and delta-HR indices to predict successful weaning from high-flow oxygen therapy in hospitalized patients with COVID-19 pneumonia. PLoS One. 2024;19(2): e0297624. https://doi.org/10.1371/journal.pone.0297624 . (PMID:38359052; PMCID:PMC10868811).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0297624</ArticleId><ArticleId IdType="pubmed">38359052</ArticleId><ArticleId IdType="pmc">10868811</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y, Jung HM, Chung SP, Chung HS, Cho Y. Failure prediction of high-flow nasal cannula at the conventional oxygen therapy phase in the emergency department. Respiration. 2024. https://doi.org/10.1159/000540004 (Epub ahead of print. PMID: 38934166).</Citation></Reference><Reference><Citation>Saffarini L, Sabobeh N, Lasfer C, Kazim S. High-flow nasal cannula in COVID-19 patients with moderate to severe respiratory distress: a retrospective analysis. Cureus. 2024;16(1): e52518. https://doi.org/10.7759/cureus.52518 . (PMID:38371128;PMCID:PMC10874283).</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.52518</ArticleId><ArticleId IdType="pubmed">38371128</ArticleId><ArticleId IdType="pmc">10874283</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li C, Chang W, Liu L. High-flow nasal cannula reduces intubation rate in patients with COVID-19 with acute respiratory failure: a meta-analysis and systematic review. BMJ Open. 2023;13(3): e067879. https://doi.org/10.1136/bmjopen-2022-067879 . (PMID:36997243; PMCID:PMC10069279).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-067879</ArticleId><ArticleId IdType="pubmed">36997243</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>